Literature DB >> 19719772

Pre-S2 deletion mutants of hepatitis B virus could have an important role in hepatocarcinogenesis in Asian children.

Kenji Abe1, Swan N Thung, Han-Chieh Wu, Tung Thanh Tran, Phuc Le Hoang, Khai Dinh Truong, Ayano Inui, Ja June Jang, Ih-Jen Su.   

Abstract

Although many studies on the risk factors and their carcinogenesis in adult hepatocellular carcinoma (HCC) have been reported, they remain poorly understood in childhood HCC. A retrospective study of 42 HCC cases in Asian children was conducted. Hepatitis B virus (HBV)-DNA in HCC tissues was detected in 36 of 42 (86%) cases tested, while no hepatitis C virus (HCV)-RNA was detectable in any of HCCs. Twenty of 36 (56%) HCC cases were accompanied by cirrhosis. Surprisingly, very high prevalence of the HBV pre-S deletion mutant was recognized in 27 of 30 (90%) HCCs examined. They occurred most frequently in pre-S2 (20/27, 74%) followed by pre-S1 (5/27, 18.5%), and both pre-S1/S2 (2/27, 7.4%). Interestingly, the pre-S2 mutant consistently appeared with deletion at nt 4-57 in all of the 20 cases with the pre-S2 mutant (100%) and within this locus in the two cases with both pre-S-1/S2 mutants. Type II ground-glass hepatocytes in non-tumorous livers were seen in 15 of the 22 HCCs with the pre-S2 deletion mutant (68%). This hotspot mutation in the pre-S2 was further confirmed by complete genomic sequence of HBV in a Japanese boy who eventually developed HCC. Our result strongly suggests that HBV is a major contributor to the development of HCC in Asian children. The HBV pre-S2 deletion mutant at nt 4-57 which has a CD8 T-cell epitope could be responsible for the emergence and aggressive outcome of childhood HCC. Determination of this hotspot mutation in the pre-S2 region could be a useful index for predicting the clinical outcome of HCC development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19719772     DOI: 10.1111/j.1349-7006.2009.01309.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  26 in total

Review 1.  Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes.

Authors:  Yuan-Chi Teng; Zhao-Qing Shen; Cheng-Heng Kao; Ting-Fen Tsai
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  Pre-s mutation is a significant risk factor for hepatocellular carcinoma development: a long-term retrospective cohort study.

Authors:  Dong Hyun Sinn; Moon Seok Choi; Geum-Youn Gwak; Yong-Han Paik; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  Dig Dis Sci       Date:  2012-09-30       Impact factor: 3.199

Review 3.  Overview of hepatitis B viral replication and genetic variability.

Authors:  Shuping Tong; Peter Revill
Journal:  J Hepatol       Date:  2016-04       Impact factor: 25.083

4.  HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing.

Authors:  Jennifer Audsley; Margaret Littlejohn; Lilly Yuen; Joe Sasadeusz; Anna Ayres; Christopher Desmond; Tim Spelman; George Lau; Gail V Matthews; Anchalee Avihingsanon; Eric Seaberg; Frances Philp; Melissa Saulynas; Kiat Ruxrungtham; Gregory J Dore; Stephen A Locarnini; Chloe L Thio; Sharon R Lewin; Peter A Revill
Journal:  Virology       Date:  2010-07-23       Impact factor: 3.616

5.  Sequence analysis and functional characterization of full-length hepatitis B virus genomes from Korean cirrhotic patients with or without liver cancer.

Authors:  Huailiang Zhou; Dina Gewaily; Sang Hoon Ahn; Carina Preskill; Yongxiang Wang; Li Zong; Jing Zhang; Kwang-Hyub Han; Jack Wands; Jisu Li; Shuping Tong
Journal:  Virus Res       Date:  2017-04-01       Impact factor: 3.303

Review 6.  Pediatric hepatitis B treatment.

Authors:  Haruki Komatsu; Ayano Inui; Tomoo Fujisawa
Journal:  Ann Transl Med       Date:  2017-02

7.  Deep sequencing analysis of quasispecies in the HBV pre-S region and its association with hepatocellular carcinoma.

Authors:  An-Ye Zhang; Ching-Lung Lai; Fung-Yu Huang; Wai-Kay Seto; James Fung; Danny Ka-Ho Wong; Man-Fung Yuen
Journal:  J Gastroenterol       Date:  2017-03-28       Impact factor: 7.527

Review 8.  Clinical significance of hepatitis B surface antigen mutants.

Authors:  Nicola Coppola; Lorenzo Onorato; Carmine Minichini; Giovanni Di Caprio; Mario Starace; Caterina Sagnelli; Evangelista Sagnelli
Journal:  World J Hepatol       Date:  2015-11-28

9.  Quantitative evaluation of hepatitis B virus mutations and hepatocellular carcinoma risk: a meta-analysis of prospective studies.

Authors:  Yang Yang; Jiang-Wei Sun; Long-Gang Zhao; Freddie Bray; Yong-Bing Xiang
Journal:  Chin J Cancer Res       Date:  2015-10       Impact factor: 5.087

10.  Novel approach to identifying the hepatitis B virus pre-S deletions associated with hepatocellular carcinoma.

Authors:  Zhi-Mei Zhao; Yan Jin; Yu Gan; Yu Zhu; Tao-Yang Chen; Jin-Bing Wang; Yan Sun; Zhi-Gang Cao; Geng-Sun Qian; Hong Tu
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.